Thank you for the message; I appreciate your investment in T2 Biosystems. I recognize our stock is down ~60% since in joined on Jan 9th ($1.14 vs. $0.45). As you know, the market has been severely impacted by COVID-19 and that is disappointing to all. We are focused on creating value and, in the midst of a global pandemic, we have materially strengthened our balance sheet and secured a contract with the nation’s largest group purchasing organization (Vizient), providing access and contracted pricing to over 50% of the acute care hospitals in the U.S. market.
I am happy to have a phone call to reiterate our corporate priorities (i.e., what we are doing to build value). Let me know your phone number and the best time to call.